Negative Press Doesn't Change UBS View on Horizon Pharma (HZNP)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. DFTX
7. BAUFF
8. ICE
9. KR
10. RGA

Go back to Negative Press Doesn't Change UBS View on Horizon Pharma (HZNP)

Express Scripts (ESRX) Says Horizon Pharma (HZNP) Represented 40% of Linden Claims - Bloomberg, Citing Spokesperson

November 11, 2015 3:19 PM EST

Express Scripts (NASDAQ: ESRX) says Horizon Pharma (NASDAQ: HZNP) represented 40 percent of Linden claims, according to Bloomberg, citing a company spokesperson.

... More

Horizon Pharma (HZNP) Issues Commentary on Express Scripts' (ESRX) Business Practices

November 11, 2015 12:12 PM EST

(NOTE - The following follows an earlier statement made by Horizon.)

Horizon Pharma plc (Nasdaq: HZNP) commented on Express Scripts' (Nasdaq: ESRX) business practices.

"Our philosophy of ensuring that patients get the medicine their doctors prescribe is threatening Express Scripts' profiteering and exposing what we believe is a lack of care for... More

Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - Mizuho

November 11, 2015 11:57 AM EST

Mizuho Securities analyst Irina Koffler reiterated a Buy rating and $34 price target on Horizon Pharma (NASDAQ: HZNP), saying they expect minimal impact from Linden disruption.

Koffler commented, "We spoke with management and learned that Linden processes ~150-200 prescriptions for Duexis, Vimovo, Pennsaid, and... More